Therapy News and Research

RSS

Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers

Our cells rely on tightly regulated signaling pathways to control when they grow, divide, and survive. When these regulatory systems are disrupted, cells can acquire the ability to grow uncontrollably and become cancerous.

25 Jun 2026

New diagnostic platform enables automated HER2 scoring of breast cancer tissue samples

Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform combining lensfree holography and deep learning for automated HER2 scoring of breast cancer tissue samples.

25 Jun 2026

European project receives €15 million to study phage-based therapies

Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known as phages.

25 Jun 2026

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 25 Jun 2026

Three courageous heart transplant survivors are celebrated by the British Heart Foundation for giving their old hearts for research

The British Heart Foundation is celebrating three incredible young women who donated their old hearts to science after having heart transplant surgery.

25 Jun 2026

FDA approves palbociclib combination for advanced HR-positive HER2-positive breast cancer

Today, Alliance Foundation Trials, LLC (AFT) was informed that the U.S. Food and Drug Administration has approved palbociclib in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for adult patients with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–positive (HER2+) locally advanced or metastatic breast cancer following induction treatment.

24 Jun 2026

Immunotherapy may help women with early ovarian insufficiency to conceive babies

A pilot study from Karolinska Institutet shows that immunotherapy may enable stimulation of egg maturation in women with autoimmune POI (premature ovarian insufficiency) – a condition that usually leads to infertility.

24 Jun 2026

Modulating pathogenic scar cells promotes spinal cord regeneration

SCI often causes long-term motor and sensory deficits because the damaged tissue does not simply heal like many peripheral tissues.

24 Jun 2026

Open source tool automates data reanalysis to detect rare diseases

A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses.

24 Jun 2026

AACR report highlights unequal burden of cancer in the United States

The American Association for Cancer Research (AACR) today released its Cancer Disparities Progress Report 2026, a comprehensive analysis of the unequal burden of cancer in the United States.

24 Jun 2026

Study outlines legal challenges for fetal tissue research in Japan

Human fetal tissue research has contributed to advances in developmental biology, the study of congenital diseases, regenerative medicine, and vaccine development.

24 Jun 2026

LMU researchers discover new genetic cause of Crohn's disease

A team led by LMU physician Daniel Kotlarz has identified a previously unknown genetic cause of Crohn's disease.

24 Jun 2026

Eating 90 g of wholegrains daily linked to lower breast cancer risk

Research indicates that long-term wholegrain intake per Nordic guidelines is associated with reduced breast cancer risk, emphasizing food type differences.

24 Jun 2026

Micro and nanorobots could transform blood clot treatment

Newer tethered devices address some of these limitations: the "milli‑spinner" thrombectomy device applies compressive and shear loading to compact a clot to about 10% of its original volume, enabling ultrafast removal even in pulmonary and cerebral arteries (in vitro and porcine studies).

23 Jun 2026

Scientists unlock molecular structure of key protein linked to cancer, neurological diseases

After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structures of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases.

23 Jun 2026

Gene therapy shows promise against deadly childhood liver disease

A new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that model this disease by researchers at UCL and Great Ormond Street Hospital.

23 Jun 2026

Lifetime estrogen exposure linked to improved brain health in women

Researchers from the University of Kansas have shown a link between reproductive hormone exposure throughout life and brain health in 459 women aged 65 to 80.

23 Jun 2026

UCI Health launches world's first embryonic stem cell trial for Huntington's disease

UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world's first in-human embryonic stem cell-derived clinical trial for Huntington's disease.

23 Jun 2026

Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment.

23 Jun 2026

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

23 Jun 2026

Previous
1
...
24
25
26
27
28
29
30
...
2932
Next

Therapy News and Research

Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers

New diagnostic platform enables automated HER2 scoring of breast cancer tissue samples

European project receives €15 million to study phage-based therapies

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Three courageous heart transplant survivors are celebrated by the British Heart Foundation for giving their old hearts for research

FDA approves palbociclib combination for advanced HR-positive HER2-positive breast cancer

Immunotherapy may help women with early ovarian insufficiency to conceive babies

Modulating pathogenic scar cells promotes spinal cord regeneration

Open source tool automates data reanalysis to detect rare diseases

AACR report highlights unequal burden of cancer in the United States

Study outlines legal challenges for fetal tissue research in Japan

LMU researchers discover new genetic cause of Crohn's disease

Eating 90 g of wholegrains daily linked to lower breast cancer risk

Micro and nanorobots could transform blood clot treatment

Scientists unlock molecular structure of key protein linked to cancer, neurological diseases

Gene therapy shows promise against deadly childhood liver disease

Lifetime estrogen exposure linked to improved brain health in women

UCI Health launches world's first embryonic stem cell trial for Huntington's disease

Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

Synthetic protein hybrid offers promising treatment for liver diseases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News